Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Sakuma

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
International Journal of Cardiology|December 4, 2014
Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individualsToshio Hayashi, Kiyoshi Kubota, Seinosuke Kawashima, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|November 6, 2008
A robot assisted hip fracture reduction with a navigation systemSanghyun Joung, Hirokazu Kamon, Hongen Liao, et al.
BMJ Open|May 18, 2022
Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study)Hiroshi Nomoto, Sho Furusawa, Akinobu Nakamura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 7, 2018
Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　- Insights From GARFIELD-AFYukihiro Koretsune, Takuma Etoh, Yousuke Katsuda, et al.
Biomedicine Hub|January 16, 2023
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding StudyYoshikazu Miwa, Akiko Mutoh, Takeshi Morimoto, et al.
Endocrine Journal|July 3, 2020
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administrationMasashi Isshiki, Ichiro Sakuma, Yasuaki Hayashino, et al.
Journal of Molecular and Cellular Cardiology|January 20, 2007
S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic heartsHiroshi Asanuma, Kunihiko Nakai, Shoji Sanada, et al.
JACC. Advances|August 12, 2024
Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome: Insights From the REAL-CAD StudyHiroshi Iwata, Katsumi Miyauchi, Ryo Naito, et al.
Diabetes Research and Clinical Practice|September 29, 2022
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D studyKenichi Kito, Hiroshi Nomoto, Ichiro Sakuma, et al.
International Heart Journal|March 6, 2018
Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) TrialKatsumi Miyauchi, Takeshi Kimura, Hiroaki Shimokawa, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
International Journal of Cardiology|December 4, 2014
Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individualsToshio Hayashi, Kiyoshi Kubota, Seinosuke Kawashima, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|November 6, 2008
A robot assisted hip fracture reduction with a navigation systemSanghyun Joung, Hirokazu Kamon, Hongen Liao, et al.
BMJ Open|May 18, 2022
Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study)Hiroshi Nomoto, Sho Furusawa, Akinobu Nakamura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 7, 2018
Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　- Insights From GARFIELD-AFYukihiro Koretsune, Takuma Etoh, Yousuke Katsuda, et al.
Biomedicine Hub|January 16, 2023
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding StudyYoshikazu Miwa, Akiko Mutoh, Takeshi Morimoto, et al.
Endocrine Journal|July 3, 2020
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administrationMasashi Isshiki, Ichiro Sakuma, Yasuaki Hayashino, et al.
Journal of Molecular and Cellular Cardiology|January 20, 2007
S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic heartsHiroshi Asanuma, Kunihiko Nakai, Shoji Sanada, et al.
JACC. Advances|August 12, 2024
Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome: Insights From the REAL-CAD StudyHiroshi Iwata, Katsumi Miyauchi, Ryo Naito, et al.
Diabetes Research and Clinical Practice|September 29, 2022
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D studyKenichi Kito, Hiroshi Nomoto, Ichiro Sakuma, et al.
International Heart Journal|March 6, 2018
Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) TrialKatsumi Miyauchi, Takeshi Kimura, Hiroaki Shimokawa, et al.
Pageof 26